Welcome to our dedicated page for AKTIS ONCOLOGY news (Ticker: AKTS), a resource for investors and traders seeking the latest updates and insights on AKTIS ONCOLOGY stock.
Aktis Oncology, Inc. reports clinical-stage oncology developments centered on targeted radiopharmaceuticals for solid tumors. The company’s miniprotein radioconjugate platform supports AKY-1189, a Nectin-4 program with potential across urothelial, breast, non-small cell lung, colorectal, cervical, and head and neck cancers, and AKY-2519, a B7-H3 program for prostate, lung, colorectal, and other solid tumors.
Recurring updates include FDA actions such as IND clearances and Fast Track designation, clinical-trial initiations, imaging and dosimetry data presentations, business and financial results, investor-conference participation, and board and committee changes. News also covers Aktis’ collaboration with Eli Lilly and Company to develop radioconjugates outside its proprietary pipeline.
Akoustis Technologies (NASDAQ: AKTS) has expanded its intellectual property portfolio with the issuance of nine new patents, bringing the total to 47 issued patents and 78 pending as of April 23, 2021. These patents focus on BAW resonators, piezoelectric materials, and various RF filter technologies for 5G and WiFi 6 applications. The company is ramping up production capacity at its New York facility and aims to deliver innovative solutions to meet increasing market demands in mobile and wireless sectors.
On April 26, 2021, Akoustis Technologies (NASDAQ: AKTS) announced an investor update call scheduled for May 3, 2021, at 8:00 a.m. ET. The call will include a business update and a Q&A session. The company is actively producing WiFi 6 tandem filter solutions and shipping multiple 5G small cell XBAW® filters. Akoustis has recently expanded its product catalog with 15 new filters, including those for WiFi and 5G applications. The firm leverages advanced manufacturing techniques to support the growing RF filter market.
Akoustis Technologies (NASDAQ: AKTS) has announced new WiFi 6E XBAW filter modules enhancing the 5 GHz WiFi spectrum. The 5.6 GHz and 6.6 GHz modules enable the utilization of additional 80 MHz and 160 MHz channels across the UNII 1-4 and UNII 5-8 bands. A tier-1 OEM has placed the first order for these filters, aimed at developing MU-MIMO products. Commercial production is anticipated in late 2021 to early 2022. The company's strategy includes expanding its New York manufacturing facility to support growing demand.
On April 5, 2021, Akoustis Technologies (NASDAQ: AKTS) announced that its XBAW WiFi 6E coexistence filter solutions received approval for use in multiple chipsets from a tier-1 SoC manufacturer. The filters cover crucial frequency bands for WiFi 6E devices. The company is experiencing rapid acceptance of its products, which is expected to broaden its sales channels. Additionally, Akoustis plans to expand production capacity in New York, addressing the growing demand for high-performance RF filters as global governments allocate new wireless spectrums.
Akoustis Technologies (NASDAQ: AKTS) announced a significant milestone by securing a WiFi 6E reference design with a Tier 1 SoC vendor. This design utilizes the 5.5 GHz and 6.5 GHz XBAW filter modules, enhancing sales opportunities for Akoustis's filters in next-gen routers. The reference design is expected to be available in the second half of calendar 2021. With the FCC's recent approval of additional unlicensed spectrum, demand for high-performance filters is expected to rise. Akoustis is also ramping up production capacity to meet the increasing demand for its RF filter solutions.
Akoustis Technologies (NASDAQ: AKTS) announced its participation in the 33rd Annual Roth Conference from March 15-17, 2021. The company’s management will engage in a fireside chat at 11:00 am ET on March 15, which will be webcast live. Akoustis is focused on high-performance XBAW® RF filters for 5G, WiFi, and radar applications, entering production across multiple markets in 2020. The company plans to expand its New York fabrication facility due to a growing backlog and is launching several new filter products to meet increasing demand.
Akoustis Technologies (NASDAQ: AKTS) announced that holders of its 6.5% Convertible Senior Notes due 2023 converted their notes into equity, resulting in the issuance of 4,983,633 shares of common stock. This discharge of indentures eliminates all associated liens, enhancing the company’s financial standing. Akoustis is ramping up production of its XBAW® RF filters for various applications, including 5G and Wi-Fi, and plans to expand its manufacturing capacity in New York to meet growing demand.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced its participation in the Loop Capital 2021 Investor Conference on March 11-12, 2021. The event will be conducted virtually due to Covid-19. Interested investors can schedule meetings via their Loop Capital representative or by reaching out to Akoustis’ investor relations. The company has seen increasing interest in its XBAW® RF filters, which support 5G applications, high-band WiFi, and radar systems. Akoustis is also expanding production capacity in New York to meet growing demand for its new filters and solutions.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announces participation in the Tenth Annual Susquehanna Technology Conference from March 9-11, 2021. Due to Covid-19, the event will be virtual. The Company is gaining traction with its high-frequency XBAW® RF filters, expanding its product line to include filters for 5G and WiFi 6 markets. They plan to scale production capacity at their New York facility in response to a growing backlog. Akoustis has added 15 new filters to its catalog, targeting both commercial and defense sectors, while pursuing advancements in next-gen materials and semiconductor manufacturing.
Akoustis Technologies, Inc. (NASDAQ: AKTS) announced a design win and volume order for its 3.6 GHz XBAW® filter solution aimed at last-mile connectivity, targeting network operators. The customer anticipates ramping production in the second half of 2021. This order follows significant interest in Akoustis' XBAW® filter portfolio post-CBRS auctions, which provided new spectrum for cellular carriers. The company also revealed a 500% capacity expansion plan for its New York facility to meet anticipated demand and recently added 15 new filters to its catalog for various market applications, including 5G and WiFi 6E.